About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
Response Assessment and Utility of MRD in Multiple Myeloma
By
MyCancerHaven
FEATURING
Ravi Vij
,
Adriana Rossi
By
MyCancerHaven
FEATURING
Ravi Vij
,
Adriana Rossi
236 views
July 6, 2023
Click here to learn more about MyCancerHaven:
https://www.mycancerhaven.org/
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
25:23
Houston Methodist Hospital
Whole-Body MRI: Past, Present, and Future
Feat.
N. Gupta
23:34
MyCancerHaven
Experts Discuss the Diagnosis and Management of High-Risk Multiple M…
Feat.
R. Vij,
M. Alsina
41:54
University of Colorado Division of Hematology
Overview of Pathophysiology, Diagnosis and Management of Multiple My…
Feat.
K. Sidor
10:23
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …
Feat.
T. Einarsson Long
26:24
Dana-Farber Cancer Institute
Myeloma 101: Diagnosis, Prognosis & Risk
Feat.
N. Munshi
42:37
University of Colorado Department of Medicine
Multiple Myeloma in 2023: An Oncological Success Story
Feat.
P. Forsberg
10:13
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: MM
Feat.
K. Patel
47:04
Dana-Farber Cancer Institute
Future Directions for Novel & Next Gen Therapy in the Management…
Feat.
P. Richardson
45:43
MedNews Week
Multiple Myeloma in 2022: Developments, Directions, and Disparities
Feat.
J. Mikhael
20:28
Dana-Farber Cancer Institute
The PROMISE of Early Detection and Interception in Myeloma
Feat.
I. Ghobrial
19:18
Total Health
Updates to Management of Patients With Multiple Myeloma
Feat.
S. Kumar
22:33
5th SOHO Italy Annual Conference
SOHO Italy 2023: How & When to Integrate Flow Cytometry in the D…
Feat.
B. Paiva
26:10
MyCancerHaven
Multiple Myeloma 101: Epidemiology, Diagnosis and Staging
Feat.
R. Vij,
S. Kumar
41:46
Yale Cancer Center
Early Detection and Interception in Myeloma: The PROMISE Study
Feat.
I. Ghobrial
43:50
MyCancerHaven
The Basics of Diagnostic Testing in Multiple Myeloma: How to Interpr…
Feat.
R. Vij,
C. Emmitt Cole
05:18
ecancer
Management of Multiple Myeloma in a Resource-Constrained Setting
Feat.
H. Ddungu
15:14
Philippe Moreau
EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and …
07:36
PleXus Communications
Diagnosis and Risk Stratification Considerations for MM
Feat.
A. Krishnan
30:24
University of Colorado Cancer Center
MRD in MM: How We Measure Disease Generally and What It Means for th…
Feat.
B. Harry
17:01
UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts
Newly Diagnosed MM Case Discussion: Classifying Patient Risk, and Ap…
Feat.
A. Duvall,
P. Riedell,
B. Derman,
S. Kosuri
